W. Motz

B. Strauer, W. Motz, B. Schwartzkopff, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

ACE-inhibitors and coronary microcirculation.

B. Strauer, W. Motz, M. Vogt, 1993, Basic research in cardiology.

Regression of Cardiac Hypertrophy with Pharmacotherapeutic Regimen

B. Strauer, W. Motz, S. Scheler, 1993 .

Long-term treatment in arterial hypertension for protecting hypertrophic myocardium.

B. Strauer, W. Motz, M. Vogt, 1991, Basic research in cardiology.

The inter-relationship between hypertension and ischaemic heart disease

W. Motz, S. Scheler, 1999 .

Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs

B. Strauer, W. Motz, Priv.-Doz.Dr. W. Motz, 2004, The clinical investigator.

Improvement of coronary flow reserve after long-term therapy with enalapril.

B. Strauer, W. Motz, B. Strauer, 1996, Hypertension.

Echocardiographic Findings in Sleep Apnea

B. Strauer, W. Motz, C. Bethge, 1987 .

Coronary haemodynamics in hypertensive heart disease.

B. Strauer, W. Motz, M. Vogt, 1992, European heart journal.

Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms.

B. Strauer, W. Motz, S. Scheler, 1991, The American journal of cardiology.

Reduced peripheral and coronary vasomotion in systemic hypertension.

M. Leschke, B. Strauer, M. Kelm, 1992, European heart journal.

Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension.

M. Leschke, B. Strauer, W. Motz, 1990, The American journal of cardiology.

Increased Risk of Coronary Heart Disease Death In Men With Low Total and Low-Density Lipoprotein Cholesterol In the Russian Lipid Research Clinics Prevalence Follow-up Study

R. Hauer, W. Edwards, W. Laskey, 2005 .

Positive Inotropic Drugs in the Treatment of Chronic Congestive Heart Failure: A Critical Update

B. Strauer, W. Motz, 1988 .

Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension.

B. Strauer, W. Motz, S. Scheler, 1990, The American journal of cardiology.

Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram.

B. Strauer, W. Motz, S. Scheler, 1994, The American journal of cardiology.

Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients

B. Strauer, M. Kelm, W. Motz, 1996, Journal of hypertension.

Serum thyrotropin levels predict all-cause and circulatory mortality in patients with invasively treated coronary artery disease.

H. Völzke, M. Dörr, R. Rettig, 2009, International journal of cardiology.

Regression of structural cardiovascular changes by antihypertensive therapy.

B. Strauer, W. Motz, 1984, Hypertension.

Therapeutical effects of chronic ACE-inhibition on coronary microcirculation and left ventricular hypertrophy.

W. Motz, M. Vogt, E. StrauerB, 1993 .

Coronary Vascular Changes in the Progression and Regression of Hypertensive Heart Disease

B. Strauer, W. Motz, B. Schwartzkopff, 1991, Journal of cardiovascular pharmacology.

Left ventricular function and collagen content after regression of hypertensive hypertrophy.

B. Strauer, W. Motz, 1989, Hypertension.

Differential therapy of hypertensive heart disease.

B. Strauer, W. Motz, 1990, American Journal of Cardiology.

Angiotensinogen M235T gene polymorphism and recurrent restenosis after repeated percutaneous transluminal coronary angiography.

H. Völzke, R. Rettig, W. Motz, 2002, Clinical science.

The role of hypertension, left ventricular hypertrophy and psychosocial risks in cardiovascular disease: prospective evidence from blue-collar men.

B. Strauer, J. Siegrist, R. Peter, 1992, European heart journal.

Regression of heart muscle hypertrophy after nifedipine therapy: changes in cardiac gene expression.

B. Strauer, E. Stangl, W. Motz, 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Nifedipine in the long-term management of hypertensive heart disease.

B. Strauer, W. Motz, 1983, Hypertension.

Influence of Nifedipine on Ventricular Function and Myocardial Hypertrophy in Spontaneously Hypertensive Rats

B. Strauer, W. Motz, B. Garthoff, 1983, Journal of cardiovascular pharmacology.

Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia.

A. Greinacher, H. Schwertz, W. Motz, 2009, Blood.

Ventricular Arrhythmias in Hypertensive Heart Disease With and Without Heart Failure

B. Strauer, W. Motz, C. Bethge, 1987, Journal of cardiovascular pharmacology.

Calcium-antagonism: A new therapeutic access to hypertensive heart disease

B. Strauer, W. Motz, B. Strauer, 1983 .

[Dysplastic intramyocardial arteries with subaortic septum in patients with hypertrophic obstructive cardiomyopathy].

B. Strauer, W. Motz, H. Schulte, 1992, Zeitschrift fur Kardiologie.

[PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients].

M. Leschke, E. Vester, H. Schultheiss, 1994, Zeitschrift fur Kardiologie.

Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide.

B. Strauer, M. Kelm, W. Motz, 1995, Hypertension.

[Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?].

M. Leschke, B. Strauer, W. Motz, 2008, Deutsche medizinische Wochenschrift.

Medical repair of hypertensive left ventricular remodeling.

B. Strauer, W. Motz, S. Scheler, 1992, Journal of cardiovascular pharmacology.

Brief report Megakaryocyte impairment by eptiﬁbatide-induced antibodies causes prolonged thrombocytopenia

A. Greinacher, H. Schwertz, W. Motz, 2009 .

Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications

B. Strauer, W. Motz, M. Vogt, 2004, The clinical investigator.

[Hypertrophy and coronary reserve].

W. Motz, S. Scheler, 2008, Deutsche medizinische Wochenschrift.

The influence of sympathetic nervous activity on regression of cardiac hypertrophy.

B. Strauer, W. Motz, H. M. Brecht, 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].

B. Strauer, W. Motz, M. Vogt, 1989, Zeitschrift fur Kardiologie.

Coronary circulation in arterial hypertension.

B. Strauer, W. Motz, S. Scheler, 1991, Journal of cardiovascular pharmacology.

Untreated hypertensives and their quality of life.

H. Matschinger, J. Siegrist, W. Motz, 1987, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Heart failure on the basis of hypertension.

B. Strauer, W. Motz, B. Schwartzkopff, 1993, Circulation.

Prevention of hypertensive hypertrophy by medical therapy: effects on systolic wall stress and systolic function

B. Strauer, W. Motz, 1985, Basic Research in Cardiology.

Functional and Metabolic Consequences of Chronic Alterations in Preload and Afterload in the Hypertrophied and Dilated Heart

B. Strauer, W. Motz, 1983 .

Left Ventricular Mass and Wall Stress in the Evaluation of Myocardial Performance: Functional, Metabolic, and Therapeutic Consequences in Chronic Heart Disease

B. Strauer, W. Motz, A. Kment, 1983 .

Regression of cardiac hypertrophy after therapy in animal hypertension.

B. Strauer, W. Motz, 1985, Journal of cardiovascular pharmacology.

Transient myocardial ischaemia in hypertensives: missing link with left ventricular hypertrophy.

B. Strauer, W. Motz, S. Scheler, 1992, European heart journal.

Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin).

A. Greinacher, W. Motz, P. Eichler, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans

W. Motz, B. Schwartzkopff, M. Vogt, 1997, Diabetes.

Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers

B. Stratmann, D. Tschoepe, W. Kerner, 2020, JAMA network open.

Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry

H. Heuer, M. Stoll, W. Schöls, 2011, BMC cardiovascular disorders.

Beta-oxidation of 1-[14C]-17-[131I]-iodoheptadecanoic acid following intracoronary injection in humans results in similar release of both tracers

L. Feinendegen, K. Grossmann, E. Vester, 1993, European Journal of Nuclear Medicine.

Candidate genetic markers and the risk of restenosis after coronary angioplasty.

H. Völzke, R. Rettig, C. Schwahn, 2004, Clinical science.

Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.

B. Strauer, W. Motz, S. Knauer, 1993, Circulation.

The influence of antihypertensive treatment on left ventricular compliance and myocardial stiffness

W. Motz, R. Ippisch, G. Ringsgwandl, 1983 .

Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in

W. Voelker, H. Drexler, V. Klauss, 2012, American heart journal.

One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.

H. Drexler, V. Klauss, G. Nickenig, 2007, Journal of the American College of Cardiology.

A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.

S. Silber, W. Daniel, H. Drexler, 2006, American heart journal.

Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting.

U. John, H. Völzke, W. Hoffmann, 2007, International journal of cardiology.

The role of clonidine in hypertensive heart disease. Influence on myocardial contractility and left ventricular afterload.

B. Strauer, W. Motz, R. Ippisch, 1983, Chest.

Blood Rheology in Hypertension and Hypertensive Heart Disease

M. Leschke, B. Strauer, W. Motz, 1987, Journal of cardiovascular pharmacology.

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

P. Gosse, J. Degaute, F. Zannad, 2000, Journal of hypertension.

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

M. Böhm, R. Schmieder, W. Zidek, 2008, Journal of hypertension.

[Characteristics of therapy of acute myocardial infarction in diabetes].

W. Kerner, W. Motz, de W. Motz, 2012, Herz.

[Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].

B. Strauer, W. Motz, S. Scheler, 1995, Herz.

Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis.

B. Strauer, P. Betz, W. Motz, 1992, European heart journal.

[Transient myocardial ischemia in hypertensive patients].

B. Strauer, W. Motz, S. Scheler, 1989, Zeitschrift fur Kardiologie.

Coronary flow reserve in arterial hypertension.

B. Strauer, W. Motz, M. Vogt, 1989, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].

B. Strauer, W. Motz, 1988, Zeitschrift fur Kardiologie.

Mechanisms of histamine-induced coronary vasodilatation: H1-receptor-mediated release of endothelium-derived nitric oxide.

B. Strauer, M. Kelm, W. Motz, 1993, Journal of vascular research.

Interaction between factor V Leiden and serum LDL cholesterol increases the risk of atherosclerosis.

H. Völzke, R. Rettig, W. Motz, 2005, Atherosclerosis.

ACE-inhibitors in coronary artery disease?

B. Strauer, W. Motz, M. Vogt, 1993, Basic research in cardiology.

Hyperglycemia and Cardiovascular Risk in Diabetes mellitus Type 1 and Diabetes mellitus Type 2

K. Kohnert, W. Kerner, W. Motz, 2016 .

The Role of Nitric Oxide in the Regulation of Coronary Vascular Resistance in Arterial Hypertension: Comparison of Normotensive and Spontaneously Hypertensive Rats

M. Kelm, W. Motz, M. Feelisch, 1992, Journal of cardiovascular pharmacology.

Remodeling and reparation of the cardiovascular system.

P. Armstrong, R. Devereux, M. Mulvany, 1992, Journal of the American College of Cardiology.

Regression of Cardiac Hypertrophy: Experimental and Clinical Results

B. Strauer, W. Motz, M. Klepzig, 1987, Journal of cardiovascular pharmacology.

Coronary microangiopathy and cardiac hypertrophy.

B. Strauer, W. Motz, B. Schwartzkopff, 1990, European heart journal.

Left ventricular systolic resistance in rats with hypertension and hypertrophy.

W. Motz, S G Shroff, W Motz, 1989, The American journal of physiology.